Inspire Completes Patient Enrollment In Three Late-Stage Clinical Trials In Cystic Fibrosis, Dry Eye And Blepharitis
Originally posted in Cystic Fibrosis News From Medical News Today
Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced today patient enrollment is complete in three of its late-stage clinical trials…
No Comments
RSS feed for comments on this post.
















by Raelene














